Fagron Publishes Agenda for 2024 Annual Shareholders Meeting and Extraordinary General Meeting
Fagron Publishes Agenda for 2024 Annual Shareholders Meeting and Extraordinary General Meeting
AgendaRegulated information
Nazareth (Belgium)/Rotterdam (The Netherlands), 12 April 2024 – 8AM CET
監管信息
拿撒勒（比利時）/鹿特丹（荷蘭），2024 年 4 月 12 日 — 歐洲中部時間上午 8 點
Fagron publishes agenda for 2024 annual shareholders meeting and extraordinary general meeting
法格龍發佈2024年年度股東大會和特別股東大會的議程
The Board of Directors of Fagron NV invites shareholders to attend Fagron's annual general meeting of shareholders and the extraordinary general meeting of shareholders on Monday 13 May 2024.
法格龍內華達州董事會邀請股東參加2024年5月13日星期一舉行的法格龍年度股東大會和特別股東大會。
Agenda
The agenda includes the discussion of the annual report, the approval of the annual financial statements and the dividend proposal of €0.30 for the financial year 2023, and the approval of the remuneration policy. The remuneration policy provides for an increase in the annual remuneration of the non-executive directors. Furthermore, the agenda includes the proposal to reappoint Robert ten Hoedt as independent, non-executive director. The full agenda and further details can be found in the meeting documents.
議程
議程包括討論年度報告、批准年度財務報表和2023財年0.30歐元的股息提案，以及薪酬政策的批准。薪酬政策規定增加非執行董事的年度薪酬。此外，該議程還包括重新任命羅伯特·滕·霍特爲獨立非執行董事的提議。完整的議程和更多細節可以在會議文件中找到。
Meeting and meeting documents
Fagron's annual general meeting of shareholders will be held at its statutory seat, Venecoweg 20A, 9810, Nazareth (Belgium) and by audio and video conference on Monday 13 May 2024 at 3PM CET. Immediately thereafter, the extraordinary general meeting will be held in the presence of associated civil-law notary Stijn Raes.
會議和會議文件
法格龍的年度股東大會將在其法定所在地Venecoweg 20A，9810，拿撒勒（比利時）舉行，並將於2024年5月13日星期一下午3點通過音頻和視頻會議舉行。此後，特別股東大會將立即在相關的民法公證人Stijn Raes在場的情況下舉行。
The convocation, including the agenda, and other documents related to both general meetings of shareholders can be found on the Fagron website.
會議，包括議程，以及與兩次股東大會相關的其他文件可以在Fagron網站上找到。
Further information
Karen Berg
Global Investor Relations Manager
Tel. +31 6 53 44 91 99
karen.berg@fagron.com
進一步的信息
凱倫·伯格
全球投資者關係經理
電話 +31 6 53 44 91 99
karen.berg@fagron.com
About Fagron
Fagron is a leading global company active in pharmaceutical compounding, focusing on delivering personalized medicine to hospitals, pharmacies, clinics, and patients in more than 30 countries around the world.
關於 Fagron
Fagron 是一家活躍於藥物複合領域的全球領先公司，專注於爲全球 30 多個國家的醫院、藥房、診所和患者提供個性化藥物。
Belgian company Fagron NV has its registered office in Nazareth and is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol 'FAGR'. Fagron's operational activities are managed by the Dutch company Fagron BV, which is headquartered in Rotterdam.
比利時公司Fagron NV的註冊辦事處位於拿撒勒，並在布魯塞爾泛歐交易所和阿姆斯特丹泛歐交易所上市，股票代碼爲 “FAGR”。法格隆的運營活動由總部位於鹿特丹的荷蘭公司Fagron BV管理。
In the event of differences between the English translation and the Dutch original of this press release, the latter prevails.
如果本新聞稿的英文譯本和荷蘭語原件之間存在差異，則以後者爲準。
Attachment
附件
- Fagron publishes agenda for 2024 annual shareholders meeting and extraordinary general meeting
- 法格龍發佈2024年年度股東大會和特別股東大會的議程
譯文內容由第三人軟體翻譯。